Stocks and Investing Stocks and Investing
Tue, December 3, 2024

Here's Why ResMed (RMD) is a Strong Momentum Stock


Published on 2024-12-03 13:31:43 - Thomas Matters, WOPRAI
  Print publication without navigation

  • Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank,

The article from MSN Money discusses why ResMed Inc. (RMD) is considered a strong momentum stock. It highlights that ResMed has shown significant positive momentum in its stock price, with a 1.1% increase in the last trading session, closing at $183.98. Over the past four weeks, the stock has risen by 10.6%, and over the last year, it has increased by 10.1%, outperforming the S&P 500's gains of 3.6% and 24.8% respectively. The article points out that ResMed's Momentum Style Score of B and its ranking in the top 36% of stocks in terms of forward-looking one-year price change estimates contribute to its momentum status. Additionally, positive earnings estimate revisions, with the consensus estimate for the current year increasing from $7.01 to $7.09 over the last 60 days, further support the stock's momentum. The article also mentions that ResMed's performance in terms of earnings and sales growth, along with its industry's ranking, adds to its appeal as a momentum stock.

Read the Full MSN Article at:
[ https://www.msn.com/en-us/money/topstocks/here-s-why-resmed-rmd-is-a-strong-momentum-stock/ar-AA1vckDR ]
Contributing Sources